IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i12p6526-d576628.html
   My bibliography  Save this article

Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain

Author

Listed:
  • Sebastián Videla

    (Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
    Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L’Hospitalet del Llobregat, 08907 Barcelona, Spain
    These authors contributed equally.)

  • Aurema Otero

    (Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L’Hospitalet del Llobregat, 08907 Barcelona, Spain
    These authors contributed equally.)

  • Sara Martí

    (Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
    Microbiology Department, Bellvitge University Hospital, L’Hospitalet del Llobregat, 08907 Barcelona, Spain
    Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain)

  • M. Ángeles Domínguez

    (Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
    Microbiology Department, Bellvitge University Hospital, L’Hospitalet del Llobregat, 08907 Barcelona, Spain)

  • Nuria Fabrellas

    (Department of Public Health Nursing, Mental Health and Maternal and Childhood, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain)

  • M. Pilar Delgado-Hito

    (Department of Fundamental and Medical-Surgical Nursing, School of Medicine and Health Sciences, GRIN-IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Imma Cruz

    (OSSMA (Oficina de Seguretat, Salut i Medi Ambient), University of Barcelona, 08028 Barcelona, Spain)

  • Cristian Tebé

    (Biostatistical Unit, Department of Clinical Sciences, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Teresa Vinuesa

    (Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Fernando Ardila

    (UICEC-IDIBELL (Clinical Research Organization), L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Marta Sancho

    (Gerència Territorial Metropolitana Sud, Catalan Institute of Health, L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Esteve Fernández

    (Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain
    Department of Cancer Epidemiology and Prevention, Institut Català d’Oncologia—ICO, L’Hospitalet de Llobregat, 08908 Barcelona, Spain
    Program of Epidemiology and Public Health, Institut d’Investigació Biomèdica de Bellvitge, L’Hospitalet de Llobregat, 08908 Barcelona, Spain
    Department of Clinical Sciences, School of Medicine and Clinical Sciences, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain)

  • Montserrat Figuerola

    (Gerència Territorial Metropolitana Sud, Catalan Institute of Health, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
    Joint senior authors.)

  • Francisco Ciruela

    (Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
    Joint senior authors.)

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members ( n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI: 1.2–2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI: 11.6–14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts.

Suggested Citation

  • Sebastián Videla & Aurema Otero & Sara Martí & M. Ángeles Domínguez & Nuria Fabrellas & M. Pilar Delgado-Hito & Imma Cruz & Cristian Tebé & Teresa Vinuesa & Fernando Ardila & Marta Sancho & Esteve Fer, 2021. "Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain," IJERPH, MDPI, vol. 18(12), pages 1-12, June.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:12:p:6526-:d:576628
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/12/6526/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/12/6526/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:12:p:6526-:d:576628. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.